Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Genomics-Driven Trials Built To Be Fast And Flexible

Executive Summary

Pioneering enrollment strategies are coupled with adaptive statistical designs in the next wave of basket trials from NCI, ASCO and Novartis.


Related Content

ASCO's Richard Schilsky On State-of-the-Art Oncology Trials
Master Protocols In Practice
Loxo Sees Larotrectinib As Model Form Of Oncology Drug Development
Biomarker Is King In Latest US FDA Cancer Drug Approval
Biomarker-Led Claim Is Small Step For Merck's Keytruda, Giant Leap For Cancer Indications
Puma's Neratinib SUMMIT Study Shows Potential & Pitfalls Of Precision Medicine
AML Master Protocol For Precision Medicine Developed By Nonprofit And US FDA
Biomarkers For Pancreatic Cancer To Be Tested In Multi-drug Collaborative Study
Roche's Oncology Strategy: The Long Game Comes Into Focus
Lung-MAP Patient Screening Should Translate To Cost-Savings


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts